Phase 3 data show adjunctive seltorexant eases depression and insomnia with lessened weight gain and somnolence.
Jane Tiller, MD
Advertisement
Articles by Jane Tiller, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Positive Topline Results From Phase 3 Emerge Study of DT120 ODT in Major Depressive Disorder
2
Psychiatric Pharmacogenomics: An Overview
3
Phase 2 Analysis of ML-004 for Autism Spectrum Disorder Fails to Meet Endpoint
4
Psychiatric Comorbidities in Adults With Congenital Heart Disease and the Need for Interdisciplinary Care
5